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Facial Palsy Therapy: Can Novel ‘Smart Spectacles’ Help People Smile?  
 
Summary: One third of people diagnosed with acute onset facial paralysis (facial palsy) end up with permanent 
disabilities; these can include an inability to smile. Guidelines recommend tailored facial exercises (TFEs); but 
not many patients can access this specialist therapy. ‘Smart spectacles’ (linked to a smartphone) could deliver 
TFEs to more people. A national study is reported on this new technology.  
 
Introduction: In the United Kingdom (UK), 23,000 people annually are diagnosed with facial palsy (acute onset 
facial paralysis). For nearly one third this will result in a permanent disability, including in some the inability to 
smile. In addition to initial pharmacological therapy, guidelines recommend tailored facial exercise (TFE) 
therapy repeated every day. However, not all patients are currently able to access such specialist physical 
therapy. ‘Smart specs’ (using miniaturized sensors in the frames to measure facial movement) are currently 
being developed. Linked to a smartphone, these could allow people to practice TFEs discreetly, provide 
immediate feedback, and supply data on outcomes to the patient and their clinician.  
 
Methods: Modelling of introduction of Facial Remote Activity Monitoring Eyewear (FRAME) into treatment 
pathways for patients with facial palsy. This included: (i) review on effectiveness of TFE therapy; (ii) national 
surveys (medical staff, facial therapy specialists and patients) to gather data on access to TFE therapy; (iii) 
Delphi Exercise to identify consensus on key outcome measures; and, (iv) economic modelling to estimate 
cost-effectiveness and determine a range of acceptable costs for the technology. In parallel, research to 
examine target markets to inform product development, and production of integral commercialization plan.  
 
Results: Searches short-listed ten studies to add to the three included in the 2011 Cochrane review. Surveys 
indicate approximately thirteen percent of eligible UK patients access personalized TFE therapy. Estimated 
annual expenditure on hospital treatments for facial palsy patients is currently GBP >80 million (>USD 106 
million) compared with <£0.5 million (<USD 0.66 million) on TFE therapy. Patients with permanent defects can 
suffer a loss of up to two quality-adjusted life years (QALYs). 
 
Conclusions: Findings from this study, particularly in relation to costs and benefits, will inform the design of a 
subsequent randomized controlled trial. A novel wearable technology could make a major difference to 
people’s lives, as well as generating potential efficiencies for healthcare.  
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